Blog

Sarah Louden Highlighted ASCO Direct 2025 Puerto Rico Meeting Focused on Oncology Care and Collaboration

Sarah Louden/medium.com

Jun 24, 2025, 08:55

Sarah Louden Highlighted ASCO Direct 2025 Puerto Rico Meeting Focused on Oncology Care and Collaboration

Sarah Louden, Founder and CEO of Total Health Oncology, shared a post on LinkedIn:

“ASCO Direct 2025 Puerto Rico

Nearly 100 learners joined us for this Annual Meeting! The energy was beautiful as people networked, listened and engaged, and focused on the incredible care given on this island!

We were covered by the local press and honored to have such a successful gathering of shared ideas! Thank you MSP Oncology.

Thank you to our Program Chairs Dr Bolivar Arboleda-Osorio and Dr Joel Lopez. Your commitment to the success of this program resonates with our entire team at Total Health – Oncology.

Thank you to our speakers- Veroushka Ballester Vargas, Universidad de Puerto Rico, Arturo LoAIza-Bonilla MD, St. Luke’s University Health Network, Massive Bio, Edgardo S. Santos, MD, FACP, FASCO, Bruno Bastos, M.D., Miami Cancer Institute Lourdes Guerrero, Anne ODea, The University of Kansas Cancer Center, Alexis M. Cruz Chacón MD, Ariel Perez, Joel Lopez Figueroa, Hospital Auxilio Mutuo, Vincent Ma, University of Wisconsin-Madison, Daniel Rosas, Jose Lozada, Sramila Aithal, Alliance Cancer Specialists, PC Coral Olazagatsi, Sylvester Comprehensive Cancer Center, Estelamari Rodriguez, Ricardo H. Alvarez, Ana Sandoval Leon, MARICARMEN RAMIREZ-SOLA, MPHE, CN-BM.

Thank you to every exhibitor who makes what we do possible! You are an incredible resource to the field of cancer care. Special thanks to Regeneron Pfizer Gilead Oncology and Menarini Stemline.

A big thank you to my team.
Reyna Wilhelm, Maureen Schnepf, Isaac Louden, and Veronica Tooson and Cameron Oates and Eva Capps.

We hope that the American Society of Clinical Oncology (ASCO) see the incredible work of the professionals in Puerto Rico who are always asked to do more with less and who make an enormous impact on the LatinX population from a place of care and representation!”

More posts featuring Sarah Louden on OncoDaily.

Alexis M. Cruz Chacón MD Alliance Cancer Specialists Ana Sandoval Leon Anne ODea Ariel Perez Arturo LoAIza-Bonilla MD Bolivar Arboleda-Osorio Bruno Bastos Cameron Oates cancer Daniel Rosas Edgardo S. Santos Estelamari Rodriguez Eva Capps Hospital Auxilio Mutuo Isaac Louden Joel Lopez Joel Lopez Figueroa Jose Lozada MARICARMEN RAMIREZ-SOLA Massive Bio Maureen Schnepf Menarini Stemline Miami Cancer Institute Lourdes Guerrero OncoDaily Oncology PC Coral Olazagatsi Regeneron Pfizer Gilead Oncology Reyna Wilhelm Ricardo H. Alvarez Sarah Louden Sramila Aithal St. Luke's University Health Network Sylvester Comprehensive Cancer Center The University of Kansas Cancer Center Total Health | Oncology Universidad de Puerto Rico University of Wisconsin-Madison Veronica Tooson Veroushka Ballester Vargas Vincent Ma

BEATcc Trial at ESMOGynaec25: Atezolizumab Benefits Cervical Cancer Patients Regardless of PD-L1 Status

15 Posts Not to Miss from EACR 2025

ASCO 2025 RCC Advances: Expert Insights by Ilya Tsimafeyeu

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine

Smoking and Bladder Cancer: What You Need to Know to Protect Yourself